Managing Multiple Sclerosis

Archive for December, 2006

What do you think about Biogen and Elan applying to sell Tysabri as a drug for Crohn’s Disease? According to this article at RebOrbit, that’s exactly what they plan to do.

I don’t know about some of you but I am not comfortable with the idea of using Tysabri for MS yet. I think the approval was pushed through and as we know, there have been some complications from the drug. However, I believe that all those cases involved using Tysabri in conjunction with [tag]Avonex[/tag]. Still, I think I’ll just stick with my [tag]Copaxone[/tag] and B-12 for now!

For those who suffer from [tag]Crohn’s Disease[/tag], I hope that this works out well for you. I have a cousin who suffers from it and I know it’s not pleasant to have to deal with.

You guys go on over and read that article at the link that I gave you. I think you’ll find it to be good information. An excerpt of the article is shown below:

By Jeffrey Krasner, The Boston Globe

Dec. 16–[tag]Biogen Idec Inc[/tag]. and [tag]Elan Corp[/tag]. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn’s disease.

The drug is already being evaluated as a treatment for Crohn’s by the European Medicines Agency, and both companies had long predicted they would file a Crohn’s application with the FDA by the end of the year. But in November, Biogen Idec chief executive James C. Mullen told the Globe he didn’t expect European regulators to approve the Tysabri request, and might ask the Cambridge company to conduct additional clinical trials.